Gene · 4585
Papers4,232
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,101 to 1,120 of 4,232
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Advances in the Prophylaxis of Respiratory Infections by the Nasal and the Oromucosal Route: Relevance to the Fight with the SARS-CoV-2 Pandemic. | Pharmaceutics | 2022 | 35335905 | PubTator, text mining | PubMed |
| Comparison of Trehalose/Hyaluronic Acid (HA) vs. 0.001% Hydrocortisone/HA Eyedrops on Signs and Inflammatory Markers in a Desiccating Model of Dry Eye Disease (DED). | J Clin Med | 2022 | 35329844 | PubTator, text mining | PubMed |
| RNA Sequencing of Epithelial Cell/Fibroblastic Foci Sandwich in Idiopathic Pulmonary Fibrosis: New Insights on the Signaling Pathway. | Int J Mol Sci | 2022 | 35328744 | PubTator, text mining | PubMed |
| Using bioinformatics and systems biology to discover common pathogenetic processes between sarcoidosis and COVID-19. | Gene Rep | 2022 | 35317263 | PubTator, text mining | PubMed |
| Micropapillary Breast Carcinoma: From Molecular Pathogenesis to Prognosis. | Breast Cancer (Dove Med Press) | 2022 | 35310681 | PubTator, text mining | PubMed |
| Imaging features of biliary adenofibroma of the liver with malignant transformation: a case report with literature review. | BMC Med Imaging | 2022 | 35296268 | PubTator, text mining | PubMed |
| Berberine Inhibits the Adhesion of Candida albicans to Vaginal Epithelial Cells. | Front Pharmacol | 2022 | 35295335 | PubTator, text mining | PubMed |
| Gasdermin E mediates resistance of pancreatic adenocarcinoma to enzymatic digestion through a YBX1-mucin pathway. | Nat Cell Biol | 2022 | 35292781 | PubTator, text mining | PubMed |
| Apigenin Increases Natural Killer Cytotoxicity to Human Hepatocellular Carcinoma Expressing HIF-1α through High Interaction of CD95/CD95L. | J Microbiol Biotechnol | 2022 | 35283421 | PubTator, text mining | PubMed |
| A Novel Ras--Related Signature Improves Prognostic Capacity in Oesophageal Squamous Cell Carcinoma. | Front Genet | 2022 | 35281814 | PubTator, text mining | PubMed |
| Establishment and validation of a novel immune-related prognostic signature in malignant pleural mesothelioma. | Ann Transl Med | 2022 | 35280360 | PubTator, text mining | PubMed |
| Ex-vivo mucolytic and anti-inflammatory activity of BromAc in tracheal aspirates from COVID-19. | Biomed Pharmacother | 2022 | 35272139 | PubTator, text mining | PubMed |
| Overview of the Importance of Biotics in Gut Barrier Integrity. | Int J Mol Sci | 2022 | 35270039 | PubTator, text mining | PubMed |
| Therapeutic Potential of Certain Terpenoids as Anticancer Agents: A Scoping Review. | Cancers (Basel) | 2022 | 35267408 | PubTator, text mining | PubMed |
| Single-Cell Transcriptome Comparison of Bladder Cancer Reveals Its Ecosystem. | Front Oncol | 2022 | 35265520 | PubTator, text mining | PubMed |
| Circular RNA coiled-coil domain containing 66 regulates malignant development of papillary thyroid carcinoma by upregulating La ribonucleoprotein 1 via the sponge effect on miR-129-5p. | Bioengineered | 2022 | 35264065 | PubTator, text mining | PubMed |
| The impact of the genetic background in a patient with papillary thyroid cancer and familial adenomatous polyposis. | Arch Endocrinol Metab | 2022 | 35263052 | PubTator, text mining | PubMed |
| Clinical utility of PDX cohorts to reveal biomarkers of intrinsic resistance and clonal architecture changes underlying acquired resistance to cetuximab in HNSCC. | Signal Transduct Target Ther | 2022 | 35260570 | PubTator, text mining | PubMed |
| Depletion of transmembrane mucin 4 (Muc4) alters intestinal homeostasis in a genetically engineered mouse model of colorectal cancer. | Aging (Albany NY) | 2022 | 35255004 | PubTator, text mining | PubMed |
| MUC1 is a potential target to overcome trastuzumab resistance in breast cancer therapy. | Cancer Cell Int | 2022 | 35248049 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4585/papers?page=56